Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Liver Disease Diagnostics Market Grown from 2024 to 2025?

The market for diagnosing liver diseases has seen notable expansion in the past few years. We anticipate this market to escalate from $36.26 billion in 2024 to $39.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the historic period include increased instances of both acute and chronic liver disorders, a rise in the occurrence of liver diseases, an uptick in alcohol consumption, heightened awareness about liver health, and an expanding healthcare infrastructure.

What Growth Rate Is Anticipated for the Liver Disease Diagnostics Market in the Coming Years?

It is anticipated that the liver disease diagnostics market size will witness significant growth in the upcoming years, projected to reach $52.04 billion by 2029 at a compound annual growth rate (CAGR) of 7.4%. The predicted growth during the forecast period is largely due to factors such as the increase in the elderly population, escalating research & development expenditure, a surge in biopsy procedures and disease incidences, alongside the spread of telemedicine implementation. Key trends for the forecast period encompass the emergence of personalized medicine, progress in diagnostic kit technology, developments in rapid testing, technological evolution in the medical sector, and enhancements in diagnostic techniques.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Who Are the Leading Companies in the Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

What Are the Key Drivers of the Liver Disease Diagnostics Market?

The escalating trend of alcohol intake is anticipated to fuel the advancement of the liver disease diagnostics market in the future. The surge in alcohol intake is due to factors like evolving social norms, improved financial capacity, extensive accessibility, and increasing stress or mental health issues. Liver disease diagnostics play a pivotal role in scrutinizing the effects of alcohol consumption on liver wellness, aiding in detecting early indicators of liver damage such as fatty liver, hepatitis, or cirrhosis. For instance, according to the National Health Service, a government department based in England, reported in December 2022, the proportion of individuals who had alcohol in the past year escalated with age, commencing at 62% among individuals aged 16 to 24, peaking at 85% among those aged 55 to 74. Hence, the upward trend in alcohol intake is steering the expansion of the liver disease diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

What Are the Key Market Segments in the Liver Disease Diagnostics Industry?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

What Are the Latest Trends in the Liver Disease Diagnostics Market?

Prominent firms active within the liver disease diagnostics marketplace are striving to create innovative solutions, like non-invasive equipment for liver evaluation, designed to create more precise and effective diagnostic methods. A non-invasive equipment for liver evaluation is a diagnostic approach that gauges the condition of the liver through techniques such as elastography or blood tests, eliminating the requirement for invasive interventions such as biopsies. For example, in September 2024, City Imaging & Clinical, a diagnostic center based in India, introduced FibroScan, a non-invasive diagnostic apparatus for liver evaluation, targeting early detection of liver diseases like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This cutting-edge technology offers rapid and accurate quantification of liver stiffness and fat content, removing the need for invasive operations like biopsies. The process is swift, typically ranging from 5 to 15 minutes, entails the positioning of a probe on the skin above the liver. The probe releases acoustic waves, which quantifies the stiffness of liver tissue, assisting in evaluating fibrosis or scarring.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Are the Key Regional Markets in the Liver Disease Diagnostics Industry?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

This Report Delivers Insight On:

1. How big is the liver disease diagnostics market, and how is it changing globally?

2. Who are the major companies in the liver disease diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the liver disease diagnostics market right now?

4. Which products or customer segments are growing the most in the liver disease diagnostics market?

5. What factors are helping or slowing down the growth of the liver disease diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model